Dr. Kaufman-Janette is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4425 Ponce de Leon Blvd
Ste 200
Coral Gables, FL 33146Phone+1 305-443-6606Fax+1 305-443-4890
Education & Training
- University of Miami/Jackson Health SystemResidency, Dermatology, 1998 - 2001
- University of Miami/Jackson Health SystemInternship, Internal Medicine, 1997 - 1998
- University of Miami Leonard M. Miller School of MedicineClass of 1997
Certifications & Licensure
- FL State Medical License 1999 - 2026
- HI State Medical License 2016 - 2026
- CO State Medical License 2020 - 2025
- NY State Medical License 2014 - 2025
- TN State Medical License 2022 - 2025
- American Board of Dermatology Dermatology
Clinical Trials
- Study to Evaluate the Safety and Efficacy of LIPO-202 for the Reduction of Submental Subcutaneous Fat Start of enrollment: 2016 Dec 22
- Botulinum Toxin Treatment of Glabellar Lines: Efficacy and Safety Study III (BLESSIII) Start of enrollment: 2019 Apr 29
Publications & Presentations
PubMed
- Safety and Duration of Effect of 40-Unit PrabotulinumtoxinA-xvfs for the Treatment of Moderate to Severe Glabellar Lines in Adult Patients: A Phase II, Multicenter, Ra...Steven Fagien, Rui L Avelar, Sue Ellen Cox, John H Joseph, Joely Kaufman-Janette
Aesthetic Surgery Journal. 2024-08-20 - Effectiveness and Safety of Resilient Hyaluronic Acid (RHA) Dermal Fillers for the Correction of Moderate-to-Severe Nasolabial Folds in People of Color: Post Hoc Subgr...Susan Taylor, Susan Weinkle, Joely Kaufman-Janette, Conor J Gallagher, Kristie Kooken
Aesthetic Surgery Journal. 2024-03-15
Press Mentions
- Endo Will Showcase Late-Breaking Phase 3 CCH Data at the 2019 American Academy of Dermatology Annual MeetingMarch 1st, 2019
- Endo Announces Positive Results from Phase 3 Studies of Collagenase Clostridium Histolyticum (CCH) in Patients with CelluliteNovember 7th, 2018
- Revance Will Wait to Seek Backing for Botox-RivalDecember 14th, 2017
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: